Literature DB >> 3053920

Diagnosis and successful treatment of fusariosis in the compromised host.

W G Merz1, J E Karp, M Hoagland, M Jett-Goheen, J M Junkins, A F Hood.   

Abstract

We present six cases of fusariosis caused by Fusarium solani that were diagnosed over a three-year period in 166 adult patients undergoing chemotherapy for acute leukemia. Necrotic skin lesions were evident in four patients, fungemia in three, and a deep cellulitis around a great toe nail at the time of a febrile illness in two. The mean minimal inhibitory concentration (MIC) of amphotericin B was 3.3 micrograms/mL and of miconazole, 5.3 micrograms/mL; all isolates were resistant to 5-fluorocytosine. All patients received amphotericin B (1.0-1.5 mg/kg per d) plus 5-fluorocytosine. In contrast to results found in the literature, five patients had resolution of their infections, and the one patient who died had necropsy evidence of disseminated fusariosis. Review of our cases and of the literature did not reveal a definitive source for the organism or its portal of entry. Fusarium spp. must be recognized as opportunistic pathogens that cause a potentially fatal infection in compromised patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053920     DOI: 10.1093/infdis/158.5.1046

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies.

Authors:  L Kaufman; P G Standard; M Jalbert; D E Kraft
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.

Authors:  A Reuben; E Anaissie; P E Nelson; R Hashem; C Legrand; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 4.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

5.  Three cases of infection with Fusarium species in neutropenic patients.

Authors:  M Nucci; N Spector; S Lucena; P C Bacha; W Pulcheri; A Lamosa; A Derossi; M J Caiuby; J Macieira; H P Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

Review 6.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

7.  N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.

Authors:  A J De Lucca; T J Walsh; D J Daigle
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 8.  Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.

Authors:  Herman A Carneiro; Jeffrey J Coleman; Alejandro Restrepo; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

Review 9.  Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience.

Authors:  Sameer S Kadri; Kenneth E Remy; Jeffrey R Strich; Juan Gea-Banacloche; Susan F Leitman
Journal:  Transfusion       Date:  2015-04-09       Impact factor: 3.157

10.  Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia.

Authors:  B H Segal; T J Walsh; J M Liu; J D Wilson; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.